Synapse

← Clinical Pharmacology Advances and Applications

Papers in Clinical Pharmacology Advances and Applications

Page 2 · newest first

  1. Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A ReviewClinical Pharmacology Advances and Applications · 2022
  2. Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid ResponseClinical Pharmacology Advances and Applications · 2022
  3. Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory HypercholesterolemiaClinical Pharmacology Advances and Applications · 2022
  4. Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019Clinical Pharmacology Advances and Applications · 2022
  5. Evaluating Pharmacists’ Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi ArabiaClinical Pharmacology Advances and Applications · 2022
  6. Exenatide Once Weekly for Management of Type 2 Diabetes: A ReviewClinical Pharmacology Advances and Applications · 2022
  7. Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A ReviewClinical Pharmacology Advances and Applications · 2022
  8. Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on BrigatinibClinical Pharmacology Advances and Applications · 2022
  9. Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese ExperienceClinical Pharmacology Advances and Applications · 2021
  10. Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: ReviewClinical Pharmacology Advances and Applications · 2021
  11. Pharmacological Management of Urinary Incontinence: Current and Emerging TreatmentClinical Pharmacology Advances and Applications · 2021
  12. Comparing the Efficacy of a Nurse-Driven and a Physician-Driven Diabetic Ketoacidosis (DKA) Treatment ProtocolClinical Pharmacology Advances and Applications · 2021
  13. A Case of Thrombocytosis Associated with Enoxaparin Therapy in an AdolescentClinical Pharmacology Advances and Applications · 2021
  14. Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and SelinexorClinical Pharmacology Advances and Applications · 2021
  15. Evaluation of Antimalarial Activity of 80% Methanolic Root Extract of Dorstenia barnimiana Against Plasmodium berghei–Infected MiceClinical Pharmacology Advances and Applications · 2021
  16. Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D2/D3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 InhibitorClinical Pharmacology Advances and Applications · 2021
  17. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 StudyClinical Pharmacology Advances and Applications · 2021
  18. Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese PerspectiveClinical Pharmacology Advances and Applications · 2021
  19. Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant BacteriaClinical Pharmacology Advances and Applications · 2021
  20. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee PainClinical Pharmacology Advances and Applications · 2021
  21. Determination of Caffeine and Hydrogen Peroxide Antioxidant Activity of Raw and Roasted Coffee Beans Around Habru Woreda, Ethiopia Using UV-Vis SpectroscopyClinical Pharmacology Advances and Applications · 2021
  22. Clinical Impact of Liraglutide as a Treatment of ObesityClinical Pharmacology Advances and Applications · 2021
  23. Efficacy of Generic Atorvastatin in a Real-World SettingClinical Pharmacology Advances and Applications · 2021
  24. Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I TrialsClinical Pharmacology Advances and Applications · 2021
  25. Penetration of Flurbiprofen from a Locally Applied Sore Throat Lozenge and Spray into Cadaveric Human Pharynx Tissue: A Novel ex vivo Model and Microautoradiography MethodClinical Pharmacology Advances and Applications · 2021
  26. The Impact of First-Line Anti-Tubercular Drugs’ Pharmacokinetics on Treatment Outcome: A Systematic ReviewClinical Pharmacology Advances and Applications · 2021
  27. Safety and Tolerability of PCSK9 Inhibitors: Current InsightsClinical Pharmacology Advances and Applications · 2020
  28. An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 DiseaseClinical Pharmacology Advances and Applications · 2020
  29. Vitamin D Pretreatment Attenuates Ciprofloxacin-Induced Antibacterial ActivityClinical Pharmacology Advances and Applications · 2020
  30. Hypoglycemic and Antihyperglycemic Activities of 80% Methanol Root Extract of Acanthus polystachyus Delile (Acanthaceae) in Type 2 Diabetic RatsClinical Pharmacology Advances and Applications · 2020
  31. Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR®) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and SimulationClinical Pharmacology Advances and Applications · 2020
  32. Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial StudyClinical Pharmacology Advances and Applications · 2020
  33. Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in JapanClinical Pharmacology Advances and Applications · 2020
  34. Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current PerspectivesClinical Pharmacology Advances and Applications · 2020
  35. Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical StudiesClinical Pharmacology Advances and Applications · 2020
  36. Phytochemical and Antiulcer Activity Screening of Seed Extract of Cordia africana Lam (Boraginaceae) in Pyloric Ligated RatsClinical Pharmacology Advances and Applications · 2020
  37. Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart FailureClinical Pharmacology Advances and Applications · 2020
  38. Overexpression of Adiponectin Receptors in Opium Users with and without CancerClinical Pharmacology Advances and Applications · 2020
  39. Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control StudyClinical Pharmacology Advances and Applications · 2020
  40. Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary InterventionClinical Pharmacology Advances and Applications · 2020
  41. Determination of the Permeation and Penetration of Flurbiprofen into Cadaveric Human Pharynx TissueClinical Pharmacology Advances and Applications · 2020
  42. Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult VolunteersClinical Pharmacology Advances and Applications · 2019
  43. A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese SubjectsClinical Pharmacology Advances and Applications · 2019
  44. Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetesClinical Pharmacology Advances and Applications · 2019
  45. Approach to residual dizziness after successfully treated benign paroxysmal positional vertigo: effect of a polyphenol compound supplementationClinical Pharmacology Advances and Applications · 2019
  46. Novel approaches to treating advanced systemic mastocytosisClinical Pharmacology Advances and Applications · 2019
  47. Role of the pharmacist in improving inhaler technique and asthma management in rural areas in JordanClinical Pharmacology Advances and Applications · 2019
  48. Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteersClinical Pharmacology Advances and Applications · 2019
  49. Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitusClinical Pharmacology Advances and Applications · 2019
  50. Reproducibility of nasal allergen challenge responses in adults with allergic rhinitisClinical Pharmacology Advances and Applications · 2019